	Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial. JAMA Brakedal B, Skeie GO, Derad C, Alstadhaug KB, Anundskås I, Berven H, Biermann M, Bjørnarå KA, Torres Cleuren YN, Dalbro SEJ, Eidelberg D, Foldnes K, Fortes G, Haugarvoll K, Herlofson K, Hustad E, HogenEsch RI, Johanson GAS, Johnsen SH, Kunszt K, Kverneng S, Labusau A, Lie IH, Lilleng H, Lundervold K, Lundqvist C, Ma Y, McCann A, Njølstad TH, Pihlstrøm L, Riemer F, Rognerud AK, Sheard E, Simonsen AM, Storm E, Svensen M, Toker L, Tunold JA, Dölle C, Friede T, Tzoulis C. PMID: 42848371 [PubMed - as supplied by publisher]
	Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations. J Parkinsons Dis Schneider RB, Skibinski G, Fiske B, Kopil CM, Merchant K, Simuni T. PMID: 42847638 [PubMed - as supplied by publisher]
	Safer Mobility Behavior Assessment and Intervention for People With Parkinson's Disease: A Modified Delphi Study. OTJR (Thorofare N J) Cheung D, Paul SS, Mackenzie L, Wesson J, Allen NE. PMID: 42847526 [PubMed - as supplied by publisher]
	Profiling peripheral immune cells in Parkinson's disease: A scoping review. J Parkinsons Dis Recinto SJ, Jernigan Posey JE, Lefter N, Vitic Z, Overgaard MØ, Liu L, Howden AJ, Eyer K, Romero-Ramos M, Tansey MG, Stratton JA. PMID: 42847443 [PubMed - as supplied by publisher]
	Dual targeting of melatonergic and serotonergic neurotransmissions in Parkinson's disease: role of agomelatine. Neurodegener Dis Manag Al-Kuraishy HM, Naji MT, Abd Hasan RR, Eliwa D, Batiha GE. PMID: 42847162 [PubMed - as supplied by publisher]
	Gut-brain immune dysregulation in Parkinson's disease: a hypothesis-forming narrative review of trained immunity. Front Aging Neurosci Tang M, Li J, Zhang C, Tu R, Wang S. PMID: 42846826 [PubMed]
	Efficacy and Safety of Safinamide as an Adjunct to Levodopa for Motor Fluctuations in Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Parkinsons Dis Ahmed AAO, Ahmed OAO, Dishean AS, Gilbert C, Elkheir MMAS, Sota HA, Abdulaziz MAM, Mahmoud EYM, Ahmed RAO. PMID: 42846716 [PubMed]
	Trigonelline Alleviates Neuroinflammation in AAV-SynA53T Parkinson's Disease Model Mice: Involvement of PI3K/AKT-NF-ÎºB Signaling and Gut Microbial-Metabolic Remodeling. Food Sci Nutr Chen M, Dong Y, Zheng J, Lin Y, Li Q, Wei C, Zhuo L, He Y, Sun J, Fu F, Liu J. PMID: 42846692 [PubMed]
	Association Between Relative Fat Mass and Parkinson's Disease in American Adults: A Large Cross-Sectional Study From NHANES. Parkinsons Dis Chu Q, Cao W. PMID: 42846690 [PubMed]
	Cross-sectional stratification of fall-related vulnerability in Parkinson's disease through multimodal fusion of speech, gait, facial expression, and upper-limb movement. Front Digit Health Skaramagkas V, Boura I, Karamanis G, Pentari A, Michou E, Marias K, Fotiadis DI, Kefalopoulou Z, Spanaki C, Tsiknakis M. PMID: 42846665 [PubMed]
	Bibliometric analysis of dietary patterns in Parkinson's disease: from Mediterranean diet to emerging trends. Front Aging Neurosci Yu T, Nie T, Mai Q, Wang L, Hu Z, Wu M, Pan M, Liang Y, Liu H. PMID: 42846143 [PubMed]
	Gut-brain axis dysfunction in Parkinson's disease: a meta-analysis of microbiome dysbiosis and intestinal barrier markers. Front Med (Lausanne) Mehrotra P, Vengadakrishnan K, Mehrotra P, Dan S. PMID: 42845985 [PubMed]
	Prior Parkinson's disease diagnosis and subsequent self-reported psychological resilience in the UK Biobank. Front Psychol Xu Z, Yang G, Li N. PMID: 42845951 [PubMed]
	Explainable deep learning-based classification of Wolff-Parkinson-White electrocardiographic signals. Front Physiol Ragonesi A, Fresca S, Gillette K, Kurath-Koller S, Plank G, Zappon E. PMID: 42845767 [PubMed]
	Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials. Mov Disord Corvol JC, Tesson C, Liot S, Carvalho S, Castelnovo G, Damier P, Defebvre L, Giordana C, Houeto JL, Marques A, Meissner WG, Remy P, Thobois S, Fabbri M, Rascol O, NS. PMID: 42845097 [PubMed - as supplied by publisher]
	Oral sodium butyrate alleviates motor deficits and dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's disease rat model. BMC Neurosci Yang ST, Chen YC, Kao TJ, Kuo CW, Chen CL, Huang SW, Chung SY, Fan HY, Tsai WL. PMID: 42844586 [PubMed - indexed for MEDLINE]
	Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits. Parkinsonism Relat Disord Huang H, Ruan P, Wang Y, Liu Z, Wu Y, Zhang Z, Jiang X, Fu P. PMID: 42844068 [PubMed - as supplied by publisher]
	Hyaluronic acid-based CeOâ‚‚ nanozymes for brain-targeted Parkinson's disease therapy: Biointerface design, multifunctional neuroprotective regulation and future perspectives: A review. Int J Biol Macromol Huang Q, Sun Y, Duan Y, Chen Y, Wang L, Wu X, Guan B, Liu C. PMID: 42843479 [PubMed - as supplied by publisher]
	Norepinephrine modulates the microglial response and protects against MPTP-induced Parkinson's disease pathology through regulation of the PI3K/AKT/mTOR pathway. Exp Neurol Yin H, Zhao D, Wang Y. PMID: 42843444 [PubMed - as supplied by publisher]
	Baseline CSF and plasma glucocerebrosidase activity predict longitudinal cognitive decline in Parkinson's disease: A PPMI longitudinal cohort study. J Clin Neurosci Kazemi E. PMID: 42843141 [PubMed - as supplied by publisher]

Articles 1 - 20 / 59126

Page 1 of 2957



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy